Javascript must be enabled to continue!
Feasibility and effects of non-invasive ventilation during pulmonary rehabilitation in patients with hypercapnic interstitial lung disease
View through CrossRef
Background
Aim of this study was to investigate the feasibility and the effects of non-invasive ventilation (NIV) during pulmonary rehabilitation (PR) in hypercapnic patients with interstitial lung disease (ILD).
Methods
In this retrospective analysis hypercapnic (NIV initiated) and normocapnic ILD-patients admitted to a specialized PR were analyzed. Standardized PR was performed in all ILD-patients. Pulmonary function tests, blood-gas analysis, 6-min walk distance (6MWD) and a health-related quality of life (HRQL) (SF-36) were assessed on admission and discharge.
Results
Data of 29 ILD-patients with NIV (PR for 25±19 days) were compared with those of 319 normocapnic ILD-patients (PR for 25±13 days). In contrast to the normocapnic group, NIV patients were initially more impaired regarding PaO
2
, PaCO
2
, vital capacity (all p<0.0001), total lung capacity (p=0.012) and O
2
demand (p=0.041). PR was associated with an improvement in 6MWD of 64 meters (95% CI [45 - 84], p<0.0001) in NIV patients, and of 43 meters (95% CI [37 - 49], p<0.0001) in the non NIV-patients (difference 21 meters, 95% CI [0.5, 41.8], p=0.045). In NIV-patients pCO
2
levels dropped slightly from 50.6±9.0 to 49.0±6.4 mmHg during PR. PR with NIV improved mental health summary score (SF-36) (9.3, 95% CI [4.8 - 13.9], p<0.0001) but not physical summary score (0.7, 95% CI [-2.1 - 3.4], p=0.63). There was no difference between the two groups with regard to changes in HRQL. No adverse events were registered in patients with NIV during PR.
Conclusions
NIV during PR in ILD-patients seems to be feasible and safe. It may improve exercise capacity and HRQL even in patients with hypercapnic ILD.
European Respiratory Society (ERS)
Title: Feasibility and effects of non-invasive ventilation during pulmonary rehabilitation in patients with hypercapnic interstitial lung disease
Description:
Background
Aim of this study was to investigate the feasibility and the effects of non-invasive ventilation (NIV) during pulmonary rehabilitation (PR) in hypercapnic patients with interstitial lung disease (ILD).
Methods
In this retrospective analysis hypercapnic (NIV initiated) and normocapnic ILD-patients admitted to a specialized PR were analyzed.
Standardized PR was performed in all ILD-patients.
Pulmonary function tests, blood-gas analysis, 6-min walk distance (6MWD) and a health-related quality of life (HRQL) (SF-36) were assessed on admission and discharge.
Results
Data of 29 ILD-patients with NIV (PR for 25±19 days) were compared with those of 319 normocapnic ILD-patients (PR for 25±13 days).
In contrast to the normocapnic group, NIV patients were initially more impaired regarding PaO
2
, PaCO
2
, vital capacity (all p<0.
0001), total lung capacity (p=0.
012) and O
2
demand (p=0.
041).
PR was associated with an improvement in 6MWD of 64 meters (95% CI [45 - 84], p<0.
0001) in NIV patients, and of 43 meters (95% CI [37 - 49], p<0.
0001) in the non NIV-patients (difference 21 meters, 95% CI [0.
5, 41.
8], p=0.
045).
In NIV-patients pCO
2
levels dropped slightly from 50.
6±9.
0 to 49.
0±6.
4 mmHg during PR.
PR with NIV improved mental health summary score (SF-36) (9.
3, 95% CI [4.
8 - 13.
9], p<0.
0001) but not physical summary score (0.
7, 95% CI [-2.
1 - 3.
4], p=0.
63).
There was no difference between the two groups with regard to changes in HRQL.
No adverse events were registered in patients with NIV during PR.
Conclusions
NIV during PR in ILD-patients seems to be feasible and safe.
It may improve exercise capacity and HRQL even in patients with hypercapnic ILD.
Related Results
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Time to Start Up: CT-Basted Radiomics in Children’s Lung Diseases
Time to Start Up: CT-Basted Radiomics in Children’s Lung Diseases
Radiomics is a new interdisciplinary field and a fusion product consisting by large data technology and medical image to aid diagnosis. Radiomics can gather information from differ...
Evaluation of Reperfusion Pulmonary Edema by Extravascular Lung Water Measurements After Pulmonary Endarterectomy
Evaluation of Reperfusion Pulmonary Edema by Extravascular Lung Water Measurements After Pulmonary Endarterectomy
Objectives:
Reperfusion pulmonary edema is a specific complication of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Extravascular lung wat...
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
<p dir="ltr"><b>BACKGROUND:</b><br><br>Most forms of pulmonary hypertension carry unsatisfactory prognosis with the notable exception of chronic throm...
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
<p dir="ltr"><b>BACKGROUND:</b><br><br>Most forms of pulmonary hypertension carry unsatisfactory prognosis with the notable exception of chronic throm...
Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease
Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease
Pulmonary rehabilitation is recommended for patients with chronic lung diseases including idiopathic pulmonary fibrosis according to international guidelines. However, data for pat...

